Vaccine News and Research

Latest Vaccine News and Research

Dialysis patients with kidney failure more likely to develop serious complications from flu

For most people, the flu is a temporary setback that makes them feel under the weather for a week or two. For dialysis patients with kidney failure, however, the flu is a serious health threat that can lead to pneumonia and other life-threatening complications.

1 Oct 2011

Viewpoints: Sebelius on improving care; Samuelson on health costs; Durenberger on exporting U.S. system

Far too many Americans still go without the best care. That's why the Obama administration has joined with Truman Medical Centers and more than 2,500 other hospitals nationwide, along with thousands of employers, health insurers, provider organizations and patient advocates, to launch the Partnership for Patients … Over the next three years, we will reduce preventable injuries in hospitals by 40 percent. And we will cut hospital re-admissions by 20 percent, targeting the return trips that should never have occurred.

1 Oct 2011

Poll: 21.4% of Americans believe vaccines can cause autism

More than one-quarter of Americans are concerned about the value and safety of vaccines and 21.4 percent believe vaccines can cause autism, according to the Thomson Reuters-NPR Health Poll.

1 Oct 2011

Meeting with Bill Gates, Nigerian President Jonathan re-affirms country's commitment to eradicating polio within two years

In a meeting at the presidential villa on Thursday, Nigerian President Goodluck Jonathan told Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "that he was determined to eradicate polio within two years after the crippling disease re-emerged earlier this year," Agence France-Presse reports.

1 Oct 2011

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

Researchers at the Moffitt Cancer Center in Tampa, Fla., and colleagues have found that tumor cell resistance to a specific cancer immunotherapy designed to kill cancer cells can be blamed on a mechanism that involves the production of a free radical peroxynitrite (PNT) that causes resistance to therapeutic cancer-killing cells.

30 Sep 2011

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Galectin Therapeutics Inc. today announced that it posted a new corporate presentation video to its website, www.galectintherapeutics.com, that highlights the Company's leadership position in developing galectin-inhibiting therapeutics to treat fibrosis and cancer.

30 Sep 2011

Several barriers to providing decent health care to poor people in developing countries

If you want to provide poor people in developing countries with decent health care, you need to overcome several barriers at the same time. That is the conclusion of researcher Bart Jacobs, based on years of research in Cambodia - and on his experience in several other low- and mid-income countries. The local community and existing social networks play an important role, but the authorities also have a role to play.

30 Sep 2011

Study highlights importance of prior planning before introduction of new vaccines

Proper planning before the introduction of new vaccines into a developing country's active immunization program could prevent storage problems and transportation bottlenecks that decrease the availability of existing vaccines by as much as two-thirds, according to a University of Pittsburgh study.

30 Sep 2011

Small Phase I trial shows HIV vaccine candidate is most powerful to date

Researchers at the Spanish Superior Scientific Research Council (CSIC) have successfully completed a small Phase I human clinical trial of an HIV vaccine candidate that granted 90 percent of 30 study participants an immunological response against the virus, Gizmag reports.

30 Sep 2011

Increased focus on vaccine for dengue fever is critical to curb spread of disease

In this GlobalPost opinion piece, Zulfiqar Bhutta, Husein Laljee Dewraj professor and head of the Division of Maternal and Child Health at the Aga Khan University Medical Center in Karachi, Pakistan, and Ciro de Quadros, executive vice president of the Sabin Vaccine Institute and former director of the Division of Vaccines and Immunization at PAHO, examine the need for a dengue fever vaccine as Pakistan struggles to curb an outbreak of the disease that to date has killed 60 people and has infected more than 8,000.

30 Sep 2011

Adult male circumcision not a cost effective anti-HIV tactic, panel of economists says

A panel of economists commissioned by the Copenhagen Consensus Centre who "conducted a first-ever cost-benefit analysis of the top AIDS-fighting approaches by comparing the costs of prevention and treatment options per lives saved ... said Wednesday that adult male circumcision, a global priority for preventing HIV infection, is not nearly as cost-effective as other methods of prevention," USA Today reports.

30 Sep 2011

Poor hospital supplies could spell danger for vulnerable patients

It was found that most hospitals operate with less than a month's supply of many essential medicines, leaving patients vulnerable if local distributors are unable to import them through fragile international supply chains.

29 Sep 2011

Powerful HIV vaccine being tested on humans

Spanish researchers have developed a prototype of a vaccine against the AIDS-causing HIV virus that is “much more powerful” than those made to date.

29 Sep 2011

Bill Gates arrives in Nigeria to discuss polio eradication efforts

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, arrived in Nigeria on Tuesday, where he held talks with government officials and traditional leaders to discuss polio eradication efforts in the country's worst-hit northwestern region, Agence France-Presse reports (9/27).

29 Sep 2011

Appalachia pediatricians less likely to encourage HPV vaccination than other area doctors

Pediatricians in Appalachia are less likely than doctors in other areas to encourage parents to have their children receive the human papillomavirus (HPV) vaccine, according to a new study.

29 Sep 2011

Researchers identify 'programmed cell death' pathway in parasitic worms

Researchers from the Walter and Eliza Hall Institute have for the first time identified a 'programmed cell death' pathway in parasitic worms that could one day lead to new treatments for one of the world's most serious and prevalent diseases.

29 Sep 2011

Latest research from world's leading allergists to be presented at ACAAI 2011 meeting

Be among the first to hear the latest research from the world's leading allergists presented at the 2011 annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI), Nov. 3-8, in Boston.

29 Sep 2011

Salk Institute professor named 2011 recipient of NIH Director's T-R01 program

Dr. Fred Gage, a professor in the Salk Institute Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, has been named a 2011 recipient of the prestigious National Institutes of Health (NIH) Director's Transformative Research Projects (T-R01) program.

29 Sep 2011

Scaling up communication and coordination biggest challenge in GAVI's $1B vaccine initiative

In this post in the Huffington Post's "Impact" blog, Orin Levine, executive director of the International Vaccine Access Center at Johns Hopkins University, responds to the GAVI Alliance's announcement on Tuesday that it will supply more than $1 billion in childhood vaccines to 37 of the world's poorest countries, writing, "As the Alliance takes perhaps the most significant step ever toward increasing access to lifesaving immunization with this new and exciting round of country approvals, the challenge will be to ensure that every piece of the puzzle is in place to deliver on GAVI's tremendous promise."

29 Sep 2011

Post-Soviet economic breakdown may have contributed to re-emergence of NTDs in Central Asia

According to an article by Peter Hotez, president of the Sabin Vaccine Institute, and Ken Alibek of Nazarbayev University in Astana, Kazakhstan, published Tuesday in the journal PLoS Neglected Tropical Diseases, Central Asia "continues to suffer from a post-Soviet economic breakdown that may have contributed to a re-emergence of several NTDs in the area, especially among its most economically disadvantaged groups," a PLoS press release states.

29 Sep 2011

Vaccine News and Research

Latest Vaccine News and Research

Dialysis patients with kidney failure more likely to develop serious complications from flu

Viewpoints: Sebelius on improving care; Samuelson on health costs; Durenberger on exporting U.S. system

Poll: 21.4% of Americans believe vaccines can cause autism

Meeting with Bill Gates, Nigerian President Jonathan re-affirms country's commitment to eradicating polio within two years

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Several barriers to providing decent health care to poor people in developing countries

Study highlights importance of prior planning before introduction of new vaccines

Small Phase I trial shows HIV vaccine candidate is most powerful to date

Increased focus on vaccine for dengue fever is critical to curb spread of disease

Adult male circumcision not a cost effective anti-HIV tactic, panel of economists says

Poor hospital supplies could spell danger for vulnerable patients

Powerful HIV vaccine being tested on humans

Bill Gates arrives in Nigeria to discuss polio eradication efforts

Appalachia pediatricians less likely to encourage HPV vaccination than other area doctors

Researchers identify 'programmed cell death' pathway in parasitic worms

Latest research from world's leading allergists to be presented at ACAAI 2011 meeting

Salk Institute professor named 2011 recipient of NIH Director's T-R01 program

Scaling up communication and coordination biggest challenge in GAVI's $1B vaccine initiative

Post-Soviet economic breakdown may have contributed to re-emergence of NTDs in Central Asia

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in